These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11683018)

  • 1. A look at pharmaceutical ads.
    Salyer D
    Surviv News (Atlanta Ga); 2001 Jul; ():6-7. PubMed ID: 11683018
    [No Abstract]   [Full Text] [Related]  

  • 2. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery.
    Findlay S
    Mark Health Serv; 2002; 22(1):20-5. PubMed ID: 11881540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMS issues PK notice regarding ATV + TDF.
    IAPAC Mon; 2003 Sep; 9(9):203. PubMed ID: 14672069
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA gives salvage therapy testing a push forward.
    Bass E
    AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA questions San Francisco HIV/AIDS drug advertisements.
    AIDS Policy Law; 2001 May; 16(9):1, 6. PubMed ID: 11668819
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical ads in journals.
    Beary JF
    Ann Intern Med; 1992 Oct; 117(7):616; author reply 618-9. PubMed ID: 1524338
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical ads in journals.
    Liebman M
    Ann Intern Med; 1992 Oct; 117(7):617; author reply 618-9. PubMed ID: 1524341
    [No Abstract]   [Full Text] [Related]  

  • 8. When ads trump evidence: is direct-to-consumer advertising leading practice?
    Nelson R
    Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720
    [No Abstract]   [Full Text] [Related]  

  • 9. DTC drug ads in the spotlight.
    Guglielmo WJ
    Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug advertising. GAO spurs advocates to urge FDA fast-track oversight of drug ads.
    AIDS Policy Law; 2006 Dec; 22(1):1, 4. PubMed ID: 17278241
    [No Abstract]   [Full Text] [Related]  

  • 11. The looming crisis in drug pricing.
    Delaney M
    GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug ads. Some mislead consumers.
    Roberts SS
    Diabetes Forecast; 2003 Oct; 56(10):46-8. PubMed ID: 15317096
    [No Abstract]   [Full Text] [Related]  

  • 13. Collaboration studies co-receptor drug research.
    AIDS Patient Care STDS; 1998 Mar; 12(3):230. PubMed ID: 11361940
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 15. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract]   [Full Text] [Related]  

  • 16. Misinformation in HIV/AIDS care. There's more than one way to skin a virus.
    Sharp M
    Posit Aware; 2006; 17(1):14-6. PubMed ID: 16475268
    [No Abstract]   [Full Text] [Related]  

  • 17. Advertisements. FDA orders Abbott to change misleading ads for Norvir.
    AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864
    [No Abstract]   [Full Text] [Related]  

  • 18. Who reviews the ads?
    Relman AS
    N Engl J Med; 1979 Nov; 301(18):999. PubMed ID: 492232
    [No Abstract]   [Full Text] [Related]  

  • 19. On approval.
    Huff B
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract]   [Full Text] [Related]  

  • 20. Viread gets FDA nod.
    Rodriquez E
    Posit Living; 2001 Dec-2002 Jan; 10(7):33. PubMed ID: 11808509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.